Cazitel Plus XL Tablets For Dogs
Cazitel Plus XL Tablets For Dogs
Authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
Cazitel Plus XL Tablets For Dogs
Cazitel XL Tabletten für Hunde
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel175.00milligram(s)1.00Tablet
-
Pyrantel embonate504.00milligram(s)1.00Tablet
-
Febantel525.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Package description:
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-01115
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0243/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
German (PDF)
Published on: 11/04/2023
Updated on: 7/01/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 23/09/2024
Updated on: 7/01/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 11/04/2023
Updated on: 7/01/2025
How useful was this page?: